O=C(OCc1cn([C@@H]2CN(Cc3cccs3)[C@@H](c3ccc(Cl)cc3)C[C@H]2O)nn1)c1ccccc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?